Trang Ngoc Doan Pham
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Trang Ngoc Doan Pham has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
- Doan Y. Dao
Center of Excellence for Liver Disease in Viet Nam, Johns Hopkins School of Medicine, Baltimore, MD, USA
2 shared publications - Thanh Van Kim
Department of Epidemiology, Pham Ngoc Thach University of Medicine, Ho Chi Minh City, Vietnam
2 shared publications Ahmet Gurakar
Division of Gastroenterology and Hepatology, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA
1 shared publicationAmy Trang
1 shared publicationAnh N. Le
1 shared publication- Ashley M. Hughes
Department of Biomedical and Health Information Sciences, College of Applied Health Sciences, University of Illinois at Chicago, Illinois, USA
1 shared publication
Latest Publications
- Open Access
- 5 August 2026
- Published by Elsevier in Human Factors in Healthcare
- Vol. 10
Teamwork in colorectal cancer screenings: A closer look at federally qualified health centers
- 5 August 2026
- Published by Elsevier in Human Factors in Healthcare
- Vol. 10
Open AccessTeamwork in colorectal cancer screenings: A closer look at federally qualified health centers
- Open Access
- 12 September 2024
- Published by Elsevier in eClinicalMedicine
- Vol. 76, 102818
Effectiveness and implementation of decentralized, community- and primary care-based strategies in promoting hepatitis B testing uptake: a systematic review and meta-analysis
- 12 September 2024
- Published by Elsevier in eClinicalMedicine
- Vol. 76, 102818
Open AccessEffectiveness and implementation of decentralized, community- and primary care-based strategies in promoting hepatitis B testing uptake: a systematic review and meta-analysis
- Open Access
Expanding Hepatitis B Screening with Point-of-Care Rapid Testing in Primary Care: An Implementation Science Study
Background: Vietnam faces a significant burden of hepatitis B virus (HBV) with around 10% of the population living with HBV and up to 80% unaware of their infection status. This study implemented a strategy using point-of-care rapid testing (POC-RT) for early HBV detection and linkage to care in primary care settings. The EPIS frameworks guided implementation, assessing barriers, enablers, feasibility, and acceptability. Method: The implementation plan integrated insights from participating site’s authorities, local policies, practices, and patient pathways. A mixed-methods approach was employed at three primary care clinics in North Vietnam. Each site received 200-300 POC-RT test kits for use within 10 weeks. Patients received pre- and post-screening consultations for HBV using POC-RT, followed by referrals. Quantitative and qualitative data was collected to assess barriers, enablers, feasibility, and acceptability. Results: Out of 600 POC-RT tests, 24 HBV positive cases were identified. Nine cases from public clinics received follow-up testing and specialist referrals within two weeks. Patients favored POC-RT for its simplicity, minimal blood requirement, and no cost. Physicians found POC-RT feasible for mass screenings, but noted challenges related to older adults’ skin thickness and blood volume accuracy. Linkage to care was satisfactory, but patients desired more health information during treatment. Conclusion: Implementing POC-RT at primary care settings with comprehensive consultation and linkage to care is feasible and well-received. Patient feedback underscores the need for ongoing health information during treatment and follow-up, which is vital for retention in care. Enhancing the test kit design could further enhance POC-RT uptake in the population. Research in Context: Evidence before this study: As of May 1, 2024, a comprehensive search on PubMed and Google Scholar using the terms (“HBV” or “viral hepatitis B” or “hepatitis B virus”) AND “point-of-care” AND “screening” AND “Vietnam” revealed no relevant studies specifically investigating the use of lateral capillary blood flow point-of-care rapid tests (POC-RT) for HBV screening in Vietnam. This highlights a significant gap in the literature regarding the implementation of POC-RT for HBV in this region. Added value of this study: This study is pioneering in its application of the Exploration-Preparation-Implementation-Sustainment (EPIS) framework to incorporate POC-RT for HBV screening at the primary care level in Vietnam. It adopts a universal screening approach, recommending HBV screening for all patients irrespective of their risk profiles. This is a paradigm shift in HBV testing strategy in Vietnam. Until now, HBV testing is typically based on clinical signs and symptoms of HBV related end stage liver disease in Vietnam. As a result, only an estimated 20-30% of people living with HBV are diagnosed and thus 1.32% of the eligible are on anti-viral therapies. Our proposed study suggested shifting from a model of HBsAg testing based on clinical indication to a public health model of routine community wide HBsAg testing to achieve greater absolute and more equitable reach of HBV diagnosis across demographic characteristics. Additionally, the study documents how local authorities and healthcare workers have adapted to using POC-RT and the universal screening approach in both public and private primary care facilities at central and provincial levels. Furthermore, it identifies challenges related to test selection and patient linkage to care, while also considering patient perspectives on mass screening feasibility and acceptability. Implications of all the available evidence: Given the high prevalence of HBV and the significant proportion of individuals unaware of their infection status and unscreened for HBV, Vietnam would benefit from a proactive universal screening strategy. Decentralizing screening services using POC-RT at the primary care level is strategically essential toward this universal premise. Future research should focus on broader implementation and dissemination of POC-RT in primary care and other resource-limited settings, with an emphasis on effective methods for ensuring linkage to care. Taken together, this study’s novelty lies in its systematic approach to integrating POC-RT in Vietnam’s healthcare infrastructure, potentially setting a precedent for similar interventions in other regions with high HBV prevalence and limited resources
Open AccessExpanding Hepatitis B Screening with Point-of-Care Rapid Testing in Primary Care: An Implementation Science Study
Background: Vietnam faces a significant burden of hepatitis B virus (HBV) with around 10% of the population living with HBV and up to 80% unaware of their infection status. This study implemented a strategy using point-of-care rapid testing (POC-RT) for early HBV detection and linkage to care in primary care settings. The EPIS frameworks guided implementation, assessing barriers, enablers, feasibility, and acceptability. Method: The implementation plan integrated insights from participating site’s authorities, local policies, practices, and patient pathways. A mixed-methods approach was employed at three primary care clinics in North Vietnam. Each site received 200-300 POC-RT test kits for use within 10 weeks. Patients received pre- and post-screening consultations for HBV using POC-RT, followed by referrals. Quantitative and qualitative data was collected to assess barriers, enablers, feasibility, and acceptability. Results: Out of 600 POC-RT tests, 24 HBV positive cases were identified. Nine cases from public clinics received follow-up testing and specialist referrals within two weeks. Patients favored POC-RT for its simplicity, minimal blood requirement, and no cost. Physicians found POC-RT feasible for mass screenings, but noted challenges related to older adults’ skin thickness and blood volume accuracy. Linkage to care was satisfactory, but patients desired more health information during treatment. Conclusion: Implementing POC-RT at primary care settings with comprehensive consultation and linkage to care is feasible and well-received. Patient feedback underscores the need for ongoing health information during treatment and follow-up, which is vital for retention in care. Enhancing the test kit design could further enhance POC-RT uptake in the population. Research in Context: Evidence before this study: As of May 1, 2024, a comprehensive search on PubMed and Google Scholar using the terms (“HBV” or “viral hepatitis B” or “hepatitis B virus”) AND “point-of-care” AND “screening” AND “Vietnam” revealed no relevant studies specifically investigating the use of lateral capillary blood flow point-of-care rapid tests (POC-RT) for HBV screening in Vietnam. This highlights a significant gap in the literature regarding the implementation of POC-RT for HBV in this region. Added value of this study: This study is pioneering in its application of the Exploration-Preparation-Implementation-Sustainment (EPIS) framework to incorporate POC-RT for HBV screening at the primary care level in Vietnam. It adopts a universal screening approach, recommending HBV screening for all patients irrespective of their risk profiles. This is a paradigm shift in HBV testing strategy in Vietnam. Until now, HBV testing is typically based on clinical signs and symptoms of HBV related end stage liver disease in Vietnam. As a result, only an estimated 20-30% of people living with HBV are diagnosed and thus 1.32% of the eligible are on anti-viral therapies. Our proposed study suggested shifting from a model of HBsAg testing based on clinical indication to a public health model of routine community wide HBsAg testing to achieve greater absolute and more equitable reach of HBV diagnosis across demographic characteristics. Additionally, the study documents how local authorities and healthcare workers have adapted to using POC-RT and the universal screening approach in both public and private primary care facilities at central and provincial levels. Furthermore, it identifies challenges related to test selection and patient linkage to care, while also considering patient perspectives on mass screening feasibility and acceptability. Implications of all the available evidence: Given the high prevalence of HBV and the significant proportion of individuals unaware of their infection status and unscreened for HBV, Vietnam would benefit from a proactive universal screening strategy. Decentralizing screening services using POC-RT at the primary care level is strategically essential toward this universal premise. Future research should focus on broader implementation and dissemination of POC-RT in primary care and other resource-limited settings, with an emphasis on effective methods for ensuring linkage to care. Taken together, this study’s novelty lies in its systematic approach to integrating POC-RT in Vietnam’s healthcare infrastructure, potentially setting a precedent for similar interventions in other regions with high HBV prevalence and limited resources
- Open Access
- 1 January 2022
- Published by Elsevier in SSRN Electronic Journal
Framework for HCV Micro-Elimination in Ho Chi Minh City, Viet Nam: A Path to National HCV Elimination
Background: This study leveraged the micro-elimination concept and a multi-stakeholder partnership to establish a framework for HCV elimination in Ho Chi Minh City (HCMC). The micro-elimination framework relies on accurate HCV prevalence, care cascade, and other city-specific epidemiological data. Methods: From 2019 to 2020, the probability proportionate to size sampling method was deployed to representatively invite approximately 20,000 adults (18 or older) throughout HCMC to free screening and linkage to care for HCV. Findings: In HCMC, the weighted prevalence of anti-HCV was 1·3% (95% CI, 1·1%-1·6%) and the weighted prevalence of HCV RNA was 0.60% (0·42%-0·78%). Individuals born from 1945 to 1964 represented 40·4% of all HCV cases. There were wide variations in anti-HCV rates in HCMC, including variations between districts, immigration status, risk factors, and socioeconomic statuses. A baseline HCV continuum of care for the city demonstrated that only 28·5% (85/298) of persons with anti-HCV (+) were aware of their HCV status, with 70% (60/85) diagnosing HCV incidentally, 82·7% (62/75) initiating antiHCV therapy, and 69·8% (30/43) achieving HCV cures. Interpretation: Through a multi-sector approach, an HCV micro-elimination framework for HCV elimination in HCMC was feasible to establish. There remains a considerable disease burden of HCV in HCMC of which a significant proportion was in the age group born between 1945 to 1964. Additionally, there were significant gaps in HCV awareness, screening, and access to care in the community. Thus, future interventions must have pragmatic targets, be tailored to the local needs, and emphasize screening. Funding Information: This work was supported by investigator-sponsored research grants from Gilead Sciences Inc. (Grant No: IN-US-987-5382); Roche Diagnostic International Ltd. (Grant No. SUB-000196); and in-kind donations from Abbott Diagnostic Viet Nam; Hepatitis B Foundation; Medic Medical Center, Viet Nam; and Board of Directors, Viet Nam Viral Hepatitis Alliance (V-VHA). Declaration of Interests: We declare no competing interests. Ethics Approval Statement: The study was approved by the institutional review boards at Pham Ngoc Thach University of Medicine , HCMC, Viet Nam (Approval No. 2169 DHYKPNT-NCKH, 06/07/2019 and No. 008/HDDD, 01/04/2019) and HCMC, Department of Health, HCMC, Viet Nam (Approval No. 3110/SYT-NVY, 06/14/2019).
- 1 January 2022
- Published by Elsevier in SSRN Electronic Journal
Open AccessFramework for HCV Micro-Elimination in Ho Chi Minh City, Viet Nam: A Path to National HCV Elimination
Background: This study leveraged the micro-elimination concept and a multi-stakeholder partnership to establish a framework for HCV elimination in Ho Chi Minh City (HCMC). The micro-elimination framework relies on accurate HCV prevalence, care cascade, and other city-specific epidemiological data. Methods: From 2019 to 2020, the probability proportionate to size sampling method was deployed to representatively invite approximately 20,000 adults (18 or older) throughout HCMC to free screening and linkage to care for HCV. Findings: In HCMC, the weighted prevalence of anti-HCV was 1·3% (95% CI, 1·1%-1·6%) and the weighted prevalence of HCV RNA was 0.60% (0·42%-0·78%). Individuals born from 1945 to 1964 represented 40·4% of all HCV cases. There were wide variations in anti-HCV rates in HCMC, including variations between districts, immigration status, risk factors, and socioeconomic statuses. A baseline HCV continuum of care for the city demonstrated that only 28·5% (85/298) of persons with anti-HCV (+) were aware of their HCV status, with 70% (60/85) diagnosing HCV incidentally, 82·7% (62/75) initiating antiHCV therapy, and 69·8% (30/43) achieving HCV cures. Interpretation: Through a multi-sector approach, an HCV micro-elimination framework for HCV elimination in HCMC was feasible to establish. There remains a considerable disease burden of HCV in HCMC of which a significant proportion was in the age group born between 1945 to 1964. Additionally, there were significant gaps in HCV awareness, screening, and access to care in the community. Thus, future interventions must have pragmatic targets, be tailored to the local needs, and emphasize screening. Funding Information: This work was supported by investigator-sponsored research grants from Gilead Sciences Inc. (Grant No: IN-US-987-5382); Roche Diagnostic International Ltd. (Grant No. SUB-000196); and in-kind donations from Abbott Diagnostic Viet Nam; Hepatitis B Foundation; Medic Medical Center, Viet Nam; and Board of Directors, Viet Nam Viral Hepatitis Alliance (V-VHA). Declaration of Interests: We declare no competing interests. Ethics Approval Statement: The study was approved by the institutional review boards at Pham Ngoc Thach University of Medicine , HCMC, Viet Nam (Approval No. 2169 DHYKPNT-NCKH, 06/07/2019 and No. 008/HDDD, 01/04/2019) and HCMC, Department of Health, HCMC, Viet Nam (Approval No. 3110/SYT-NVY, 06/14/2019).